The compression therapy market is expected to experience significant growth, increasing from USD 4.5 billion in 2025 to USD 5.9 billion by 2030, at a CAGR of 5.5%.
This expansion is driven by several factors, including a growing elderly population, a notable rise in chronic venous insufficiency cases, and an increase in lymphedema related to cancer treatments. Additionally, the prevalence of sedentary lifestyles and rising obesity rates has led to a surge in circulatory disorders, creating a higher demand for non-invasive treatment options.
Improvements in product comfort, the development of discreet wearable designs, and increased clinical awareness among physicians have further contributed to the adoption of compression therapy in outpatient and home settings. These trends, along with wider reimbursement coverage in key markets, continue to bolster global market growth.
However, high product costs and a lack of awareness in emerging markets constrain this growth. However, there are also significant opportunities for the market, such as product innovation in areas like antimicrobials and custom-fit solutions. Market diversification through new product launches and expansions into untapped regions could further propel growth in the compression therapy market.
This expansion is driven by several factors, including a growing elderly population, a notable rise in chronic venous insufficiency cases, and an increase in lymphedema related to cancer treatments. Additionally, the prevalence of sedentary lifestyles and rising obesity rates has led to a surge in circulatory disorders, creating a higher demand for non-invasive treatment options.
Improvements in product comfort, the development of discreet wearable designs, and increased clinical awareness among physicians have further contributed to the adoption of compression therapy in outpatient and home settings. These trends, along with wider reimbursement coverage in key markets, continue to bolster global market growth.
Compression garments dominated the market in 2024.
Compression garments lead the compression therapy market due to their extensive use in treating conditions like varicose veins, lymphedema, and chronic venous insufficiency. These products, including stockings, sleeves, and wraps, are popular because they are easy to use, available in various compression levels, and suitable for clinical settings and home care. Their increasing importance in post-surgical recovery and preventive care for at-risk populations, such as the elderly and those with sedentary lifestyles, has further driven demand. Additionally, ongoing innovations in product design, including the use of more breathable and comfortable fabrics, support their continued dominance in the market.The hospitals & clinics segment held the largest share of the compression therapy market in 2024.
Hospitals & clinics are the primary distribution channels in the compression therapy market, especially for specialty products such as pneumatic compression devices and advanced therapeutic stockings. These medical facilities play a crucial role in treating conditions like chronic venous insufficiency, lymphedema, and post-surgical recovery. The prescriptions and recommendations made by physicians in clinical settings are vital for driving demand for compression therapy products. The growing clinical acceptance and well-established benefits of compression therapy contribute to its widespread use in these environments. Consequently, hospitals & clinics stand out as the leading distribution channels.The Asia Pacific regional segment is expected to register the highest CAGR in the compression therapy market during the forecast period.
The growth in this market is driven by several factors, including an aging population in Japan and China, where venous and lymphatic issues are becoming more prevalent. Additionally, rising healthcare awareness and improvements in medical infrastructure in emerging economies like India are contributing to the increased use of compression therapy. Economic growth in the region is also elevating disposable incomes, enabling more individuals to access and afford these therapeutic products. Together, these trends, along with a growing acceptance of preventive care and post-surgical treatment, are accelerating market growth in the Asia Pacific (APAC) region.A breakdown of the primary participants referred to for this report is provided below:
- By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
- By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
- By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)
Research Coverage
This market research analyzes the compression therapy market by segmenting it according to product, technique, application, distribution channel, and region. It provides insights into key factors influencing the market, including drivers, restraints, opportunities, and challenges. The report highlights opportunities and challenges for stakeholders and offers a detailed analysis of the competitive landscape, focusing on major market players. Additionally, it examines the micromarkets in greater detail, looking at growth patterns, opportunities, and their contributions to the overall compression therapy market. The report also includes revenue generation forecasts for various market segments and identifies growth opportunities across five key regions.Key Benefits of Buying this Report
This report is valuable for both new and current players in the market, offering essential information to identify potential investment opportunities. It provides a comprehensive overview of both major and minor players, facilitating effective risk analysis and informed investment decisions. The report includes precise segmentation based on end users and geographical regions, offering detailed insights into niche market segments. Additionally, it highlights key trends, challenges, growth drivers, and opportunities, supporting strategic decision-making through a balanced analysis.Through this report, readers get insightful views into the following parameters:
The compression therapy market is experiencing growth driven by several key factors, including the increasing prevalence of chronic conditions such as venous insufficiency and lymphedema, which require long-term management. Advances in automated diagnostic tools and smart compression devices are enhancing treatment efficiency and accuracy.However, high product costs and a lack of awareness in emerging markets constrain this growth. However, there are also significant opportunities for the market, such as product innovation in areas like antimicrobials and custom-fit solutions. Market diversification through new product launches and expansions into untapped regions could further propel growth in the compression therapy market.
- Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products in the market
- Market Development: The report has elaborated the markets by segmenting the compression therapy market into different regions
- Market Diversification: New product launches, unexploited markets, recent developments, and investments in the compression therapy market
- Competitive Analysis: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as 3M (US), BSN Medical (Germany), medi GmbH & Co. KG (Germany), Sigvaris AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), DJO Global (US), JOBST (US), Therafirm (US), Bauerfeind AG (Germany), PAUL HARTMANN AG (Germany), CircAid Medical Products, Inc. (US), Tactile Medical (US), Bio Compression Systems, Inc. (US), and THUASNE (France)
Table of Contents
1 Introduction
2 Research Methodology
4 Premium Insights
5 Market Overview
6 Compression Therapy Market, by Product
7 Compression Therapy Market, by Technique
8 Compression Therapy Market, by Application
9 Compression Therapy Market, by Distribution Channel
10 Compression Therapy Market, by Region
11 Competitive Landscape
12 Company Profiles
13 Appendix
List of Tables
List of Figures
Companies Mentioned
- Solventum Corporation (3M)
- Enovis Corporation
- Bsn Medical (A Subsidiary of Essity)
- Cardinal Health
- Arjohuntleigh
- Tactile Medical
- Convatec Inc.
- Bio Compression Systems, Inc.
- Juzo GmbH
- Medi GmbH & Co. KG
- Paul Hartmann
- Sanyleg, S.R.L.
- Sigvaris Group
- Smith+Nephew
- Mego Afek, Ltd.
- Gottfried Medical, Inc.
- Thermotek, Inc.
- Bauerfeind AG
- Ofa Bamberg GmbH
- Medline Industries
- Aci Medical
- Airos Medical Inc.
- Barcelcom Têxteis, S.A
- Cizeta Medicali S.P.A
- Bösl Medizintechnik
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 279 |
Published | May 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value ( USD | $ 4.5 Billion |
Forecasted Market Value ( USD | $ 5.9 Billion |
Compound Annual Growth Rate | 5.5% |
Regions Covered | Global |
No. of Companies Mentioned | 25 |